Table 2.

Periprocedural period (d0–d30): Incidence of stroke, death, and myocardial infarction (95% confidence interval; n = 513; intention to treat).

	CEA (n = 203)	CAS (n = 197)	BMT (n = 113)	p
Any stroke or death until d30a	5 (2.5%; 0.8%–5.7%)	5 (2.5%; 0.8%–5.8%)	Not applicable	0.962b
Any stroke at d0 (only CEA/CAS)c	4 (2.0%; 0.5%–5.0%)	3 (1.5%; 0.3%–4.4%)	Not applicable	1.000±
Any stroke until d30d	5 (2.5%; 0.8%–5.7%)	5 (2.5%; 0.8%–5.8%)	0 (0.0%; 0.0%–3.2%)	0.240±
Ipsilateral stroke until d30d	4 (2.0%; 0.5%–5.0%)	5 (2.5%; 0.8%–5.8%)	0 (0.0%; 0.0%–3.2%)	0.238±
Myocardial infarctione	0 (0.0%; 0.0%–1.8%)	0 (0.0%; 0.0%–1.9%)	0 (0.0%; 0.0%–3.2%)
Any deathe	0 (0.0%; 0.0%–1.8%)	0 (0.0%; 0.0%–1.9%)	0 (0.0%; 0.0%–3.2%)

Note: CAS: carotid artery stenting; BMT: best medical treatment; CEA: carotid endarterectomy; ± : Fisher's exact test; if 0%: Confidence interval one-sided 97.5%.

^aSafety endpoint, evaluated after intervention only in patients randomized to CEA or CAS.

^bχ² test.

^cDay of intervention.

^dAfter intervention for CEA/CAS and after randomization for BMT.

^eAfter randomization.